Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Seroprevalence of Hepatitis B and C in the Eastern Himalayan Region of India: A Population-Based Study
 
Ashish Kumar Jha1, Arya Suchismita2
1Department of Gastroenterology, Indira Gandhi Institute of Medical Sciences, Patna, India. 2Gastro-Hepato Clinic, Siliguri, India. 


Corresponding Author
:
Dr Ashish Kumar Jha
Email: ashishjhabn@yahoo.co.in


Abstract

Background: Although hepatitis B and C virus (HBV and HCV) infections are endemic worldwide, there is a significant geographic variability in its distribution. There is very limited epidemiological data pertaining to the prevalence of these infections in the general population of north eastern India. 
Aim: The present population- based study was carried out to estimate prevalence of HBV and HCV infections in Eastern Himalayan region of India. It is a prospective study done over a period of one and half years from March 2013 to September 2014. Healthy persons were recruited from health camps organised at various locations in the district Darjeeling, the state of Sikkim and the neighbouring districts of West Bengal. Hepatitis B surface antigen (HBsAg ) and anti-hepatitis C virus antibodies (anti-HCV) were tested by rapid diagnostic kit which is a in-vitro immunochromatographic assay designed for qualitative evaluation. 
Results: A total of 2,314 persons were screened for HBV and HCV infections from 18 health camps in 10 locations in district of Darjeeling, state of Sikkim and the neighbouring towns. Forty seven (2.03%) and nineteen patients (0.82%) were found positive for HBsAg and anti HCV antibodies, respectively. Mirik and Kurseong had maximum prevalence rates of 6.66% (4/60) and 4.7% (8/170), respectively. 
Conclusion: The epidemiology of hepatitis C infection in Eastern Himalayan region is different from that in the rest of north-eastern India.